149 related articles for article (PubMed ID: 22714061)
21. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
22. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
[TBL] [Abstract][Full Text] [Related]
23. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
Fu G; Peng C
Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms in cardiac fibroblast growth: an obligate role for Skp2 and FOXO3a in ERK1/2 MAPK-dependent regulation of p27kip1.
Pramod S; Shivakumar K
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H844-55. PubMed ID: 24441545
[TBL] [Abstract][Full Text] [Related]
26. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H
Oncology; 2003; 65(4):355-62. PubMed ID: 14707456
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
28. Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers.
Erickson LA; Papotti M; Volante M; Jin L; Lewis JE; Lloyd RV
Endocr Pathol; 2003; 14(3):221-29. PubMed ID: 14586067
[TBL] [Abstract][Full Text] [Related]
29. Regulation of FOXO protein stability via ubiquitination and proteasome degradation.
Huang H; Tindall DJ
Biochim Biophys Acta; 2011 Nov; 1813(11):1961-4. PubMed ID: 21238503
[TBL] [Abstract][Full Text] [Related]
30. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
Fujita T; Liu W; Doihara H; Date H; Wan Y
Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
[TBL] [Abstract][Full Text] [Related]
31. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
32. p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.
Ravaioli A; Monti F; Regan MM; Maffini F; Mastropasqua MG; Spataro V; Castiglione-Gertsch M; Panzini I; Gianni L; Goldhirsch A; Coates A; Price KN; Gusterson BA; Viale G;
Ann Oncol; 2008 Apr; 19(4):660-8. PubMed ID: 18272916
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
34. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
35. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
36. DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer.
Yang YC; Tang YA; Shieh JM; Lin RK; Hsu HS; Wang YC
J Thorac Oncol; 2014 Sep; 9(9):1305-15. PubMed ID: 25122426
[TBL] [Abstract][Full Text] [Related]
37. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer.
Habashy HO; Rakha EA; Aleskandarany M; Ahmed MA; Green AR; Ellis IO; Powe DG
Breast Cancer Res Treat; 2011 Aug; 129(1):11-21. PubMed ID: 21336599
[TBL] [Abstract][Full Text] [Related]
38. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
39. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
